Selank: What It Is, Is It Legal, and Where to Buy It (2026)

Why researchers pay attention

Selank and Semax came from the same institute. Both are heptapeptides and both end with the C-terminal Pro-Gly-Pro motif. Their parent sequences differ: Selank derives from tuftsin, while Semax derives from adrenocorticotropic hormone, or ACTH. That shared design and shared origin make the pair a natural comparison, and researchers have run it directly.

A 2020 functional MRI study compared Selank and Semax in 52 healthy participants. Curo maintains a separate Semax research-material page, and the Semax ACTH-fragment research overview covers that sibling compound's origin and 2026 regulatory record. The two peptides look alike on paper and begin from different biological systems.

Human studies to date

The published human record for Selank is short and almost entirely Russian. A 2008 randomized study examined people with generalized anxiety disorder or neurasthenia. The study compared a Selank arm of 30 participants with a medazepam arm of 32 participants, 62 people in total. Its sample size and diagnostic setting define the scope of the finding, and it does not establish Selank as an approved anxiety intervention.

A separate 2008 publication returns to the immune-peptide origin. Researchers reported that Selank affected interleukin-6 gene expression and the balance of Th1 and Th2 cytokines in participants with generalized anxiety disorder or neurasthenia. Interleukin-6 and the Th1/Th2 balance are immune-signaling measures, and their inclusion shows that the antibody-fragment lineage and the anxiety work were not separate threads in the published program.

The 2020 functional MRI work asked a third question, comparing brain-connectivity patterns after Selank and Semax in healthy participants. Together these publications span comparative psychiatric research, immune signaling, and brain imaging. They do not form a registered development program. A ClinicalTrials.gov search for Selank as an intervention returns no registered Selank studies, so nothing on that registry corresponds to the Russian literature above.

Regulatory status in 2026

Selank has no FDA approval for any indication, and the agency has never taken it to a compounding advisory review.

• Selank was not among the substances reviewed at FDA's Pharmacy Compounding Advisory Committee meeting on December 4, 2024. That meeting covered AOD-9604, CJC-1295, and substances related to thymosin alpha-1.
• Selank was absent again from the July 23 and 24, 2026 committee agenda. The 2026 meeting notice listed BPC-157, KPV, TB-500, MOTS-c, emideltide, Semax, and epitalon. Semax was reviewed at that meeting; Selank was not nominated.
• One earlier FDA document mentions the compound in a compliance context. A November 10, 2021 warning letter to Advanced Nutriceuticals LLC, doing business as the Guyer Institute of Molecular Medicine, stated that a group of substances including Selank "were not nominated for inclusion on the 503A bulks list." That letter was a general compliance action against the firm, not an action over Selank specifically.

Is Selank legal to buy?

In the United States, Selank is legal to purchase as a research chemical for laboratory use. It is not a controlled substance and does not appear on any DEA schedule as of August 2026. What Selank is not: an approved drug, a dietary supplement ingredient, or a compound cleared for human or veterinary use in any form.

Three boundaries define the current picture:

1. Research sale is lawful; human-use marketing is not. FDA has repeatedly cited peptide sellers whose sites promote human use, and the courts have treated that line seriously. The owner of one vendor, Paradigm Peptides, was sentenced to 70 months in federal prison in July 2026 for selling unapproved and adulterated drugs. The offense was not stocking peptides. It was selling them for human consumption while faking the paperwork.
2. No lawful compounded form exists. Selank has never been nominated for the section 503A bulk substances list, and the 2021 warning letter states that directly. A pharmacy cannot lawfully compound it.
3. Import and state rules still apply. Selank is manufactured mostly outside the United States, and a research buyer carries the compliance burden for how the material is labeled, stored, and used. Curo's research use only policy sets out what that means in practice.

Selank is sold strictly for laboratory research, not for human or animal use.

Where to buy Selank for laboratory research

Researchers looking for where to buy Selank face a supplier market that changed sharply in 2025 and 2026. Peptide Sciences closed in March 2026, Amino Asylum went offline after a reported federal raid in June 2025, and Paradigm Peptides ended in a criminal sentencing. Several sites now trade on those dead brand names, so the first check is not price. It is whether the company behind the storefront actually exists. Our guide to the best peptide companies in 2026 covers the current field vendor by vendor.

Five checks separate a documented Selank source from an anonymous one:

1. A lot-specific COA, published before purchase. The certificate should match the exact lot printed on the vial, not a generic product-page badge. The help center shows how to verify a certificate against your lot.
2. A named, independent laboratory. A COA is only as good as the lab that issued it. Court records in the Paradigm case showed the defendants admitted faking certificates outright, which is the failure mode this check exists to catch.
3. Identity and purity by more than one method. HPLC purity alone leaves an identity gap. Selank is a small heptapeptide and truncated or deletion sequences are the realistic synthesis failure, so look for LC-MS identity confirmation and endotoxin results alongside the purity figure.
4. An identifiable company. A legal entity, a real contact route, and consistent policies. A brand name alone is not an identity, and the clone sites trading on dead vendors prove it.
5. Payment with recourse. Card payment carries buyer protection. Venmo, Zelle, and crypto-only checkouts remove it.

Curo stocks Selank 10mg in the research catalog. Every lot is tested by an independent laboratory for identity (LC-MS), purity (HPLC), and endotoxin, the full testing standard is documented, and every certificate is publicly readable without an account. Orders are fulfilled from the United States, and payment options include card, crypto, Zelle, and Cash App.

How much does Selank cost?

As of August 2026, research-grade Selank in the 10mg vial size typically runs $48 to $90 from US suppliers that publish lot-matched, independently issued COAs. Cheaper vials exist, some near $29, but they cluster among suppliers with no published lot documentation, and an unverified lot is unusable as research material at any price. Curo's Selank 10mg is $64, inside that documented tier. Compare the documentation attached to the current batch first, then the price. The pre-purchase checklist walks the full sequence.

What a Selank certificate of analysis should show

Selank is synthesized by many suppliers, so material quality is something a laboratory confirms rather than assumes. Identity, purity, endotoxin load, and fill accuracy all vary by manufacturer and by lot. A certificate worth relying on shows:

• The exact lot number that appears on the vial.
• The issuing laboratory's name and report identifier.
• HPLC purity with the chromatogram, not a bare percentage.
• Mass-spectrometry identity confirmation against the expected 751.9 g/mol, with the seven-residue sequence Thr-Lys-Pro-Arg-Pro-Gly-Pro and formula C33H57N11O9 stated on the record.
• An endotoxin result, since a pure peptide can still carry bacterial contamination from synthesis.
• A way to verify the document independently, through a public lookup or the issuing lab. Curo's COA database is open for exactly this reason.

No single identifier replaces lot matching or the three analytical methods. A well-tested lyophilized peptide can also be degraded by poor handling after receipt, so see storing research peptides and bacteriostatic water for the storage side.

For a broader framework on separating documentation from marketing when comparing suppliers, see how to evaluate research peptide companies and the companion piece on purity claims and COA batch documentation.

Further reading

Semax is the closest comparison Selank has: same institute, same heptapeptide design, same Pro-Gly-Pro tail, different parent sequence, and a very different regulatory year. Semax was reviewed at the July 2026 FDA committee meeting that never mentioned Selank. That record is set out in the Semax profile.

The same Russian research tradition produced Epitalon, a tetrapeptide known for telomere work that was carried out in cultured cells rather than in people. Its evidence is traced in Epithalon's record, from cell culture to rhesus monkeys.

Pinealon comes out of the same peptide-bioregulator programme and shows what a much shorter record looks like: three cell systems, two rodent models, and no UNII on file at FDA. The testing history is set out in Pinealon: where the EDR tripeptide has been tested.

Frequently asked questions

What is Selank?

Selank is a synthetic heptapeptide with the sequence Thr-Lys-Pro-Arg-Pro-Gly-Pro, built by adding a Pro-Gly-Pro tail to tuftsin, a four-residue fragment of the heavy chain of immunoglobulin G. It was developed in Russia, it carries CAS number 129954-34-3, and it is sold in the United States as a research chemical.

Is Selank legal to buy in the US?

Yes, as a research chemical for laboratory use. Selank is not a controlled substance as of August 2026. It is not approved for human use, it has never been nominated for the FDA section 503A bulk substances list, and no lawful compounded form exists.

Where can a researcher buy Selank?

From suppliers that publish lot-specific, independently issued COAs and operate as identifiable companies. Several well-known vendors closed or faced federal action in 2025 and 2026, and clone sites now trade on their names, so verify the company before the price. Curo lists Selank for laboratory research with every lot's certificate published openly.

How much does Selank cost?

Suppliers that publish lot-matched third-party COAs typically charge $48 to $90 for a 10mg research vial as of August 2026. Curo's 10mg vial is $64 with the lot's certificate published before purchase. Vials near $29 usually come without verifiable lot documentation.

Why is tuftsin central to Selank's story?

Tuftsin supplies Selank's first four residues, Thr-Lys-Pro-Arg, and those residues come from the heavy chain of immunoglobulin G. Adding Pro-Gly-Pro creates the seven-residue Selank sequence, linking an antibody fragment to a compound studied across anxiety, immune-signaling, and brain-imaging contexts.

Did FDA review Selank at its 2024 or 2026 committee meetings?

No. Selank did not appear among the substances reviewed at the December 4, 2024 meeting or at the July 23 and 24, 2026 meeting. It was mentioned only in the 2021 compliance letter described above.

Is there any registered clinical trial of Selank?

No. A ClinicalTrials.gov intervention search returns no registered Selank studies. The published human work consists of individual Russian literature records, including the 2008 medazepam comparison and the 2020 functional MRI study.

What should match on a Selank lot record?

The lot number should connect the material and the certificate. The sequence, formula C33H57N11O9, expected mass of about 751.9 g/mol, CAS 129954-34-3, PubChem CID 11765600, and UNII TS9JR8EP1G should align with the Selank identity record, while HPLC, LC-MS, and endotoxin testing report three distinct analytical dimensions.